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A Pseudomonas aeruginosa (isolate 416) from a patient with pneumonia, was initially
susceptible to imipenem (MIC: 2 mg/1) but became resistant to this antibiotic (isolate
470, MIC: 32 mg/1) during imipenem therapy. Treatment failed. No parallel
increases in MIC were observed for other antimicrobials tested. Isolates 416 and 470
shared the same pyocin type and serotype, produced small amounts of an inducible
^-lactamase, and had similar lipopolysaccharide compositions. On electrophoresis of
outer membrane proteins, the porin F, identified by the monoclonal antibody MA4-
4, was expressed similarly by the two isolates but the production of one band
(apparent molecular weight 47,000) was diminished in isolate 470. ["CJ-Imipenem
labelling of intact cells proceeded more slowly in 470 than in 416, especially when
bacterial cells were treated by antibody MA4-4 to block the porin F channel. ["Q-
Imipenem labelling of penicillin binding proteins (PBP) showed that the band
identified as PBP-4 bound markedly less radioactivity in isolate 470 than in 416.
After isolate 470 was passaged several times in antibiotic-free broth, the imipenem
MIC was decreased from 32 to 8 mg/1, and the [14C]-imipenem PBP pattern
recovered the initial profile as exhibited by isolate 416. Two resistance mechanisms,
affecting imipenem electively, could have combined their effect in the post-therapy
isolate, altered target protein and reduced permeability.
Introduction
On account of its broad antibacterial spectrum, imipenem has been proposed as
monotherapy for treating severe mixed infections (Neu & Labthavikhul, 1982; Williams
1985; Mayer et al., 1986). However, several recent reports (Quinn et al., 1986; Buscher
et al., 1987; Lynch, Drusano & Mobley, 1987) have documented the emergence of
imipenem resistance during imipenem therapy of Pseudomonas aeruginosa infections.
Such resistance emerged in six of ten cases of nosocomial pseudomonal pneumonia
(Salata et al., 1985). This inconvenience was encountered even though imipenem is
thought to overcome /Mactamase mediated hydrolysis and the permeability barriers of
the Gram-negative cell efficiently (Yoshimura, Zalman & Nikaido, 1983; Yoshimura &
Nikaido, 1985; Hashizume, Yamaguchi & Sawai, 1986). These are the two major
mechanisms of resistance to 0-lactam antibiotics in non-fastidious Gram-negative rods.
Notably, altered susceptibility to imipenem generally did not affect the activity of other
•Corresponding author.
57
0305-7453/90/010057+12 $02.00/0 ©1990 The British Society for Antimicrobial Chemotherapy
58 F. Bdlido et aL
0-lactam antibiotics (Quinn et al., 1986; Buscher et al., 1987; Lynch et al., 1987),
suggesting a specific resistance mechanism. This appeared to involve the reduced
expression of an outer membrane protein thought to provide a specific channel for the
penetration of imipenem.
Recently, we have observed the emergence of imipenem resistance, during imipenem
therapy, in a case of pseudomonal pneumonia. When we compared pre- and post-
therapy strains, the latter exhibited a reduced permeability to imipenem and a
decreased expression of the penicillin-binding protein PBP-4. The combination of these
two mechanisms is believed to have accounted for the imipenem resistance.
Materials and methods
Chemicals
Imipenem and [l4CJ-imipenem (6 mCi/mmol) were kindly supplied by Merck Sharp &
Dohme Research Laboratories, Rahway, New Jersey, USA; [14C]-benzylpenicillin (58-9
mCi/mmol) was purchased from Amersham, Buckinghamshire, England. The other
antibiotics were obtained from their respective manufacturers. Solutions of imipenem
were freshly prepared on the day of use.
Media
Mueller-Hinton agar (Oxoid Ltd., Basingstoke, England) was used to determine the
MICs and antibiotic Medium 3 (Difco, Detroit, Michigan, USA) was used for /?-
lactamase and outer membrane studies.
Determination of MICs
MICs were determined by an agar dilution method (Ericsson & Scherris, 1971). The
inoculum, 104—103 cfu per spot, was deposited with a multiple inoculum replicator on to
Mueller-Hinton agar containing various concentrations of antibiotics.
Serotyping
Antisera for the P. aeruginosa O-serotypes were obtained from rabbits immunized with
suspensions of the O-serotype strains that had been heated to 100°C for 2h. Slide-
agglutination was done with strains pregrown on Trypticase Soy Agar (Difco). The
suspension densities were adjusted to 109 cfu/ml by spectrophotometry (Corning Color-
imeter 252, Corning Medical, Halstead, England).
Pyocin typing
The procedure described by Fyfe, Harris & Govan (1984) was used.
fi-Lactamase studies
Crude extracts were prepared by sonication and centrifugation (Marchou et al., 1987).
^-Lactamase activity was measured in a spectrophotometer, using nitrocefin as the
substrate (Marchou et at., 1987). ^-Lactamase induction by imipenem (0-5 mg/1 for 2 h)
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was assessed as described by Gootz & Sanders (1983). One unit of /7-lactamase activity
was defined as the amount of enzyme hydrolysing 1/xmol of nitrocefin per min at room
temperature and pH 7-0, and was standardized against the protein concentration.
Bioassay of the imipencm inactivation by crude extracts from induced and non-induced
strains was performed on Mueller-Hinton agar plates as described by Levesque, Letarte
& Pechere (1983). The indicator strain was Staphylococcus aureus 209 P, a non-
penicillinase producing strain.
Analysis of outer membrane proteins
Preparation of cell membranes and outer membrane proteins was performed as
described (Marchou et al., 1987). Proteins were separated by discontinuous SDS-
polyacrylamide gel electrophoresis (PAGE) (Marchou et al., 1987). Immunoblots were
done according to the method of Towbin, Staehelin & Gordon (1979), using the
monoclonal antibody MA4-4 (Mutharia & Hancock, 1987), which recognizes the porin
F of P. aeruginosa. This monoclonal antibody was kindly provided by R. E. W.
Hancock, Vancouver, Canada.
Analysis of lipopolysaccharides (LPS)
LPS were analyzed by SDS-PAGE, followed by visualization with silver staining as
described by Tsai & Frash (1982). LPS bands were detected by immunoblotting with an
acute phase rabbit serum (Tobias, Soldau & Ulevitch, 1986).
[l4C]-Imipenem uptake of intact cells
Cells were grown in Antibiotic medium No. 3, harvested in late exponential phase
(ODSSJ: 0-75-0-80), and suspended in 50 mM phosphate buffer, pH 7 at a density of
30 g/ml (wet weight). After the cell suspension had been brought to 25°C (requiring a
20 min equilibrium time), 50/J of [14C]-labelled imipenem solution (5 mg/1) was added
to 450 /d of bacterial suspension and incubation was maintained at 25°C with shaking.
At intervals, portions of cell suspensions were rapidly removed and centrifuged
(12,000 g, 1 min, 25°Q, washed in a solution (1 g/1) of unlabelled imipenem and finally
suspended in 200 /d of distilled water. One millilitre of Kontrogel (Kontron, Zurich,
Switzerland) was added to each sample, and radioactivity was counted with a scintilla-
tion system (model LS-Z500, Beckman Instruments, Inc). Experiments were run with
or without addition of the MA4-4 antibody (dilution 1/1000) during the equilibrium
time.
Imipenem binding proteins
Direct binding of [14C]-imipenem to the inner membrane proteins were analysed as
follows. Membrane proteins (c. 200 mg/1) (prepared by the method of Marchou et al.,
1987) were incubated with [l4C]-imipenem for 10 min at 30°. Several concentrations of
the labelled antibiotic were used (50-500 mg/1), and the best result was obtained with
250 mg/1 (5/iCi/ml). This quite high concentration of [MC]-imipenem was probably
required because of the relatively low radioactivity of our material. Addition of 20 /d of
unlabelled imipenem (100 mg/1 dissolved in distilled water at 80°C and 20 /il of 20% w/
60 F. Beffldo et aL
v Sarkosyl (sodium lauroyl sarkosinatc) for 20 min at 25°C terminated the reaction and
solubilized the inner membrane. After centrifugation at 40,000 g for 30 min at 10°C,
100 /J of the supernatant was added to 25 /xl of sample buffer (the same as for the outer
membrane preparation) and 6-5 /d of /J-mercaptoethanol. Samples were incubated at
80°C for 5 min, and 65 /il (containing about 70 ng of protein) was loaded into the slots
of a 7-5-12-5% gradient SDS-PAGE gel. For fluorography, dimethyl sulphoxide
impregnated gels were soaked in 2-5-diphenyloxazole-dimethyl sulphoxide (5%, w/v)
for 2 h and then rehydrated in water for 1 h. Fluograms were obtained after exposure at
—70°C for 30 days. Apparent molecular weights of bands were estimated from the
corresponding Coomassie Blue-stained gels.
The competition assay between [l4C]-benzylpenicillin (final concentration of 30 mg/1,
4-9 /iCi/ml) with prebound unlabelled imipenem (5 mg/1) was performed under the same
conditions. The concentration of unlabelled imipenem was low enough to avoid the
saturation of the PBPs. Membrane fractions were incubated wkh imipenem for 10 min
at 30°C before addition of [14C]-benzylpenicillin.
Patient and bacteria isolated
The 56-year-old patient suffering from a post-operative abdominal infection caused by
Enterobacter cloacae, cntcrococci and P. aeruginosa, was treated with imipenem alone
(500 mg every 6 h as 30 min infusion). The condition of the patient improved for two
days but on the fifth day, the patient became septic and a diffuse pneumonia was
apparent from the chest X-rays. Imipenem-resistant P. aeruginosa strains were isolated
from both the trachea and the wound. Therapy was changed to a combination of
tobramycin and piperacillin but the patient died from sepsis a few days later.
Results
Strain identification
Among various isolates of P. aeruginosa isolated in the patient, pretherapy isolate 416
and post-therapy isolate 470 shared the same identification code (API system, API
International S.A., Geneva, Switzerland), were of pyocin type lb and O-serotype 5/16.
MICs of a variety of antibiotics (Table I) were identical for isolates 416 and 470. A
notable exception was imipenem, which was less active against isolate 470 (MIC
32 mg/1 against 2 mg/1 for isolate 416). However, after several passages in antibiotic-free
broth, the MIC of imipenem for isolate 470 decreased to 8 mg/1.
P-Lactamase studies
Basic and post-induction /Mactamase production was similar in both isolates
(Table II). The bioassay study (Figure 1) showed that, after induction, /Mactamase of
both strains protected the indicator Staphylococcus aureus similarly from the imipenem
activity. No protective effect was seen with extracts from uninduced strains.
Outer membrane studies
On SDS-PAGE of outer membrane proteins, the major change in isolate 470 was
decreased expression of a band corresponding to an apparent molecular weight of
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Table L MICs of antibiotics for isolates 416
and 470
Antibiotic
Imipenem
Amdinocillin
Pipcradllin
Carbcnicillin
SCH 34343
Ceftazidime
Cefpirome
Latamoxef
CGP 31608
BMY 28142
Gentamicin
Amikacin
Ciprofloxacin
Pefloxacin
Chloramphenicol
Tetracycline
MIC
416
2
512
4
32
128
1
1
8
4
1
0-5
1
0-05
0-5
64
16
(mg/1)
470
32*
512
4
32
128
1
1
16
4
1
0-5
1
005
0-5
64
16
The imipenem rusceptibility returned to 8 mg/1
after several nibpassages of the update in broth.
47,000 (Figure 2). This alteration remained when the imipenem MIC decreased from 32
to 8 mg/1 following subpassages (data not shown). The band migrating at a level
corresponding to a molecular weight of 35,000, and recognized as porin F by a Western
blot using the MA4-4 antibody (Figure 2) were similar in the pre- and post-therapy
isolates. Silver staining of outer membrane preparations (data not shown) displayed
similar LPS patterns. [l4C]-Imipenem labelling of the PBPs of intact cells suggesting the
existence of an altered permeability in isolate 470 (Figure 3). In the experiments carried
out without antiporin MA4-4 antibody (Figure 3(a)), significantly less radioactivity
(P < 0-05) was bound by cells of isolate 470 than with those from isolate 416 after
0-5 min of incubation. The differences observed after longer incubation did not achieve
statistical significance. When MA4-4 antibody was used to block the porin F channels
(Figure 3(b)), the difference between isolates 416 and 470 became obvious (P < 0-05)
after 1, 2 or 3 min of incubation.
Assay for binding to PBPs
After staining with Coomassie Blue but before fluography, the electrophoresed inner
membrane preparations appeared similar for isolates 416 and 470. Assays performed
with [l4C]-imipenem showed six bands, designated A to F (Figure 4). Using by analogy
Table IL 0-Lactamase activity in isolates 416 and 470
/f-Lactamase activity (mU/mg protein)
Isolate without induction after induction
416 9 60-3
470 12 88-8
8* a P.
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Flgare 2. Outer membrane proteins (OMP) patterns. Lane 0: protein standard with molecular weights as
indicated; lane 1: OMPs from isolate 416; lane 2: OMPs from isolate 470; lane 3 and 4: Western blot showing,
at molecular weight 35,000 the porin F of isolates 416 and 470, respectively. A molecular weight 47,000 band
seen in the preparation from isolate 416, disappeared in isolate 470, whereas porin F was e*picsscd similarly
in these two strains.
the Spratt's numbering system we classified these bands as A, PBP-la (apparent
molecular weight 89,000); B, PBP-lb (82,000); C, PBP-2 (69,000); D, PBP-3 (55,000); E,
PBP-4 (49,000); F, PBP-5 (30,000). These apparent molecular weights, calculated from
the corresponding Coomassie Blue stained gels, agreed with those previously reported
for the PBPs P. aeruginosa (Curtis et al., 1979). In the" susceptible isolate 416, the three
bands (C, E, F) corresponding to the main imipenem targets (PBP-2, PBP-4, PBP-5)
were particularly prominent In the resistant isolate 470, the band E (PBP-4) was
significantly less prominent The initial prominence of band E was restored in the
organism passaged in antibiotic-free broth. Competition PBP assays of [14C]-benzyl-
penicillin with prebound cold imipenem showed, in the resistant isolate 470, a labelled
band (apparent molecular weight, 50,000) that was unseen, presumably because it
became saturated with penicillin, in the parent strain (Figure 5).
Discussion
Natural, non-plasmid mediated, resistance to /Mactam antibiotic in P. aeruginosa, can
involve three mechanisms: ^-lactamase-mediated hydrolysis, altered target PBP
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Figure 3. Labelling of intact cells (10*cfu/ml) with ["CJ-imipenem after different incubation periods,
without (a) or after (b) pretreatment with anti-portn F antibody (MA4-4). •, Isolate 416; O. isolate 470.
molecules and decreased permeability of the outer membrane. The production of a
chromosomal type I /Mactamase was not the cause of imipenem resistance here, as the
isolates produced similarly small amounts of /Mactamase. Although imipenem is
considered to be highly resistant to /Mactamase-mediated hydrolysis (Neu & Labtha-
vikhul, 1982), our bioassay showed that, after induction, crude extract from either pre-
or post-therapy isolates could impair the activity of the drug. Likewise, it has been
reported recently that the self-induced /Mactamase production decreased imipenem
susceptibility of P. aeruginosa, although insufficiently to elevate MICs beyond the
clinical range (Livermore & Yang, 1987). Hence, we cannot exclude the possibility that
this slow hydrolysis might have facilitated the expression of resistance caused by
another mechanism by reducing the number of active antibiotic molecules able to reach
the target PBPs.
Previous studies have associated resistance to /Mactams with modified PBPs in
different clinical isolates of P. aeruginosa (Godfrey, Bryan & Rabin, 1981; Mirelman,
Nuchamowitz & Rubinstein, 1981) but these workers did not consider imipenem. In the
present investigation autoradiographic data showed an altered interaction of imipenem
with PBP-4 in an imipenem-resistant isolate. This change in the PBP pattern is believed
to be associated with imipenem resistance,, because repeated passages of isolate 470 in
antibiotic-free broth were accompanied with partial recovery of initial susceptibility
together with restoration of imipenem-binding to PBP-4. Even though previous investi-
gations seemed to indicate a good correlation between the activity of imipenem and its
affinity for PBP-2 (Hashizume, Yamaguchi & Sawai, 1986), the present study showed
that PBP-4 had a high binding affinity for imipenem. Moreover, the function of PBP-4
in bacteria other than Escherichia coli is largely unknown and it may be that this target
is essential in P. aeruginosa. The alteration of PBP-4 could hypothetically involve a
decreased affinity for imipenem or the instability of the acylated complex formed
between the enzyme and the antibiotic. Here we think that the second possibility was
more likely because PBP-4 affinity alterations would probably have decreased the
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Figure 4. Binding of ["CJ-imipenem to inner membrane prQteins: lane 1, isolate 416; lane 2, isolate 470; lane
3, isolate 470 after several passages in antibiotic-free broth. Letters identify the six imipenem-binding
proteins.
susceptibihty to other PBP-4-binding /Mactams such as carbenidllin or the antipseudo-
monal penem CGP 31608 (Eliopoulos et al., 1987).
The third mechanism by which P. aeruginosa can avoid or limit the lethal effects of /£-
lactam antibiotics is by reduced outer membrane permeability. Here, as in other
investigations (Quinn et al., 1986; Buscher et al., 1987; Lynch et al., 1987), the
expression of proteins of 45-49 Kd (the apparent molecular weight varied with the
study) was diminished, and the uptake of [l4C}-imipenem (see also Lynch et al., 1987)
was altered. Experiments carried out with the antiporin F antibody MA4-4 allowed a
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Figure 5. Competition PBP assays of ["CJ-benzylpenicillin with prcbound unlabelled imipenera. Lane O:
protein standards; lanes 1 and t Coomassie Blue-stained electrophoresis gels of inner membrane proteins of
isolates 416 and 470 respectively; lanes 3 and 4: ["Q-benzylpenicillin labelling of PBPs prebound with
unlabelled hnipenem, in isolates 416 and 470, respectively. Letters represent the six bands labelled in this
assay. Band B (apparent molecular weight, 50,000) is not visible in strain 416 (lane 3). These letters do not
correspond to those in Figure 4.
better understanding of the routes that imipenem uses for crossing the outer
membrane. Since the antigenic epitope of porin F recognized by MA4-4 is destroyed by
/9-mercaptoethanol as well as by cleavage of the porin with cyanogen bromide (Muth-
aria & Hancock, 1987), we assume that MA4-4 binds to cystein disulphidc bond region,
which is thought to be located at the internal face of each monomer, according to the
model proposed by Moore, Woodruff & Hancock (1985). Hence MA4-4 is likely to
disturb extensively the permeability properties of porin F. MA4-4 antibody altered the
imipenem uptake rate, suggesting that imipenem uses the porin F channel, as do most
0-lactam antibiotics (Yoshimura & Nikaido, 1983; Hancock, 1986, 1987). Experiments
using MA4-4 antibody also showed that the imipenem uptake was greatly reduced in
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the molecular weight 47,000 protein-deficient isolate 470, confirming that this protein
was involved in the process of imipenem uptake across the outer membrane.
In conclusion, two mechanisms seemed to have contributed to this emergence of
resistance during imipenem therapy. A reduction in permeability increased the MIC of
imipenem from 2 to 8 mg/1; and an unstable alteration of PBP-4 seemed associated with
a further MIC increase from 8 to 32 mg/1. The first type of mechanism has been
documented several times, but the second one seems novel. However, with the use of
new molecules exhibiting, like imipenem, high resistance to /Mactamases and better
ability to penetrate through the outer membrane, it is to be feared that bacteria could
develop such mechanisms more often in the future.
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